Want to see JP:4350 full AI Analyst Report?
Top Page
Medical System Network Co., Ltd.
(4350)
Select Model
Select Model
Rating:55Neutral
Price Target:
¥506.00
▼(-2.88% Downside)
Action:Reiterated
Date:08/18/26
The score is held back primarily by weakening earnings quality and a sharp deterioration to negative operating and free cash flow in 2026, alongside still-elevated leverage. Technicals are mixed with softer longer-term trend signals, while valuation is moderately supportive due to a reasonable P/E and a ~2.43% dividend yield.
Positive Factors
Resilient Revenue Growth
Sustained revenue expansion indicates resilient demand for the company’s healthcare and pharmaceutical support services. Continued top-line growth provides a foundation for operating leverage if management can control costs and improve profitability.
Negative Factors
Declining Profitability
Repeated net-income declines and sharply negative EPS growth indicate weakening earnings quality despite revenue expansion. Persistent cost increases or other operating pressures could limit reinvestment capacity and reduce the benefit of future sales growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Resilient Revenue Growth
Sustained revenue expansion indicates resilient demand for the company’s healthcare and pharmaceutical support services. Continued top-line growth provides a foundation for operating leverage if management can control costs and improve profitability.
Read all positive factors
Medical System Network Co., Ltd. (4350) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥15.21B
Dividend Yield2.4%
Average Volume (3M)49.94K
Price to Earnings (P/E)16.8
Beta (1Y)0.39
Revenue Growth8.19%
EPS Growth-25.81%
CountryJP
Employees4,014
SectorHealthcare
Sector Strength45
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)29.70
Shares Outstanding30,642,600
10 Day Avg. Volume63,720
30 Day Avg. Volume49,936
Financial Highlights & Ratios
PEG Ratio-0.97
Price to Book (P/B)0.91
Price to Sales (P/S)0.12
P/FCF Ratio-2.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)99.2
Revenue Forecast (FY)¥134.00B
Medical System Network Co., Ltd. Business Overview & Revenue Model
Company Description
Headquartered in Sapporo, Japan, and established in 1999, Medical System Network Co., Ltd. functions as a comprehensive provider within the healthcare industry. Its core business involves the distribution of pharmaceutical products to a diverse ra...
How the Company Makes Money
Detailed, company-specific revenue disclosures for Medical System Network Co., Ltd. (4350)—such as segment revenue breakdowns, pricing/fee structures, and named major partnerships—were not available from the information provided, so the company’s ...
Medical System Network Co., Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
58
Neutral
Cash Flow
39
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.23B | 132.19B | 122.39B | 115.36B | 109.55B | 106.69B |
| Gross Profit | 54.03B | 52.77B | 49.60B | 47.93B | 45.92B | 44.43B |
| EBITDA | 6.28B | 6.73B | 6.42B | 6.90B | 6.25B | 7.05B |
| Net Income | 870.00M | 1.07B | 1.26B | 1.86B | 1.61B | 2.39B |
Balance Sheet | ||||||
| Total Assets | 79.29B | 80.10B | 70.63B | 68.19B | 66.27B | 62.98B |
| Cash, Cash Equivalents and Short-Term Investments | 7.28B | 7.74B | 8.46B | 8.27B | 8.14B | 8.20B |
| Total Debt | 30.51B | 37.67B | 29.79B | 29.18B | 30.52B | 29.57B |
| Total Liabilities | 62.16B | 62.68B | 54.28B | 52.97B | 51.78B | 49.69B |
| Stockholders Equity | 17.00B | 17.29B | 16.26B | 15.17B | 14.45B | 13.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -5.93B | 1.75B | 5.62B | 3.37B | 1.88B |
| Operating Cash Flow | 0.00 | -3.44B | 4.46B | 7.72B | 4.97B | 4.01B |
| Investing Cash Flow | 0.00 | -4.04B | -3.73B | -3.65B | -2.11B | -2.51B |
| Financing Cash Flow | 0.00 | 6.79B | -544.00M | -3.94B | -2.92B | -3.42B |
Medical System Network Co., Ltd. Technical Analysis
Positive
521.00
Price Trends
482.38
Positive
495.56
Positive
502.50
Negative
Market Momentum
2.89
Negative
56.79
Neutral
63.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4350, the sentiment is Positive. The current price of 521 is above the 20-day moving average (MA) of 484.10, above the 50-day MA of 482.38, and above the 200-day MA of 502.50, indicating a neutral trend. The MACD of 2.89 indicates Negative momentum. The RSI at 56.79 is Neutral, neither overbought nor oversold. The STOCH value of 63.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4350.
Medical System Network Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥264.21B | 15.81 | 10.75% | 1.20% | 12.20% | -25.42% | |
69 Neutral | ¥438.35B | 13.77 | 11.29% | 3.42% | 4.32% | 0.18% | |
69 Neutral | ¥523.53B | 16.25 | ― | 1.28% | 8.72% | 3.45% | |
64 Neutral | ¥1.08T | 18.49 | 7.67% | 2.04% | ― | ― | |
55 Neutral | ¥15.21B | 16.84 | ― | 2.32% | 8.19% | -25.81% | |
54 Neutral | ¥399.48B | 23.11 | ― | 0.41% | 13.04% | -0.05% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
JP:4350
Medical System Network Co., Ltd.
500.00
36.99
7.99%
JP:9989
Sundrug Co
3,723.00
-761.84
-16.99%
JP:7649
Sugi Holdings Co
1,339.00
-507.61
-27.49%
JP:3391
TSURUHA Holdings
2,378.50
125.68
5.58%
JP:3349
COSMOS Pharmaceutical Corporation
6,569.00
-2,224.76
-25.30%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
4,097.00
240.64
6.24%
Medical System Network Co., Ltd. Corporate Events
Medical System Network Grows Healthcare Network but Faces Profit Pressure in Q1 FY2027
Aug 14, 2026
Medical System Network reported consolidated net sales of 33.14 billion yen for the first quarter of the fiscal year ending March 2027, with operating profit at 120 million yen, reflecting rising personnel and system integration costs that weighed...
Medical System Network Posts Higher Sales but Swings to Quarterly Loss, Keeps Dividend and Full-Year Guidance
Aug 7, 2026
Medical System Network reported consolidated net sales of ¥33.1 billion for the three months ended June 30, 2026, up 6.6% year on year, but profitability deteriorated sharply, with EBITDA down 26.9% and operating profit plunging 71.5%. The qu...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.